Skip to main content

ScienceDex / Researcher record

Fujii, Gary

From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.

FY2022 NIH rank #4,227
  • Rising Star
  • Long-Funded

NIH Funding · FY2022

$1.8M
Full award amounts, FY2022
5
Records listing this PI
#4,227
By linked amount among FY2022 PIs
2006
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2006$710,4872#8,073
2007$2,067,3683#2,550
2008$3,778,7297#801
2009$1,977,3554#3,352
2010$497,9712#17,565
2011$542,4732#14,408
2012$953,6041#7,432
2013$1,551,7673#3,687
2014$1,597,0893#3,847
2015$838,2423#8,453
2016$761,0763#9,724
2017$1,530,7423#3,924
2018$497,3381#18,200
2021$1,526,6962#5,139
2022$1,810,6855#4,227
2023$299,7791#34,930

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20062 records
  2. FY20073 records
  3. FY20087 records
  4. FY20094 records
  5. FY20102 records
  6. FY20112 records
  7. FY20121 record
  8. FY20133 records
  9. FY20143 records
  10. FY20153 records
  11. FY20163 records
  12. FY20173 records
  13. FY20181 record
  14. FY20212 records
  15. FY2022 · selected5 records
  16. FY20231 record

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Fujii, Gary. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2022 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2022 award records by amount

NIH award records listing Fujii, Gary as a PI. Multi-PI records show the full award amount for context.

  • 5R44HL154968-02R44Contact PI
    Non-clinical Development of a Synthetic Lung Surfactant for Treatment of NRDS
    $1M
    award amount
  • 1R43AI167312-01R43Contact PI
    VesiVax Vaccine Formulation Against Neisseria gonorrhoeae
    $299.8K
    award amount
  • 1R43AI167394-01R43Contact PI
    Niclosamide Formulations for the Treatment of Influenza Infections
    $298.5K
    award amount
  • 3R44HL154968-02S2R44Contact PI
    Non-clinical Development of a Synthetic Lung Surfactant for Treatment of NRDS
    $113.4K
    award amount
  • 3R44HL154968-02S1R44Contact PI
    Non-clinical Development of a Synthetic Lung Surfactant for Treatment of NRDS
    $67.2K
    award amount

Award organization

Organizations that administered FY2022 awards listing Fujii, Gary as a PI.

FY2022 award administered by Molecular Express, Inc. (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Molecular Express, Inc.
  2. 2006
    $500K Cumulative Funding
  3. 2006
    Entered Top 50% Nationally
    Ranked #8073
  4. 2007
    $1M Cumulative Funding
  5. 2007
    $2M Cumulative Funding
  6. 2007
    Entered Top 25% Nationally
    Ranked #2550
  7. 2008
    $5M Cumulative Funding
  8. 2008
    Entered Top 10% Nationally
    Ranked #801
  9. 2008
    Entered Top 5% Nationally
    Ranked #801
  10. 2012
    $10M Cumulative Funding